Brief: Rua Bioscience Commences Legal Proceedings Against Cann Group
Feb 15 (Reuters) - Rua Bioscience Ltd RUA.NZ :
* COMMENCES LEGAL PROCEEDINGS AGAINST CANN GROUP
* PROCEEDINGS CLAIMING DAMAGES FOR BREACH OF CONTRACTUAL
RIGHTS TO
EXCLUSIVELY SELL CANN'S MEDICINAL CANNABIS PRODUCTS IN AUSTRALIA
* OF VIEW THAT BREACHES ON AN EXCLUSIVE SUPPLY TERM PROVIDED
FOR
IN SUPPLY CONTRACT HAVE CAUSED RUA TO SUFFER SIGNIFICANT DAMAGES
Source text for Eikon: ID:n426252-2
Further company coverage: RUA.NZ
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth